Conference on Liver Disease in Africa (COLDA) 2021

Related Enduring Materials

Enduring Materials

Times are in Central Africa Time (CAT) / South African Standard Time (SAST) / Central European Summer Time (CEST).

Download the Program Book 

Download the Abstract Book

Day 1 - Thursday, 9 September 2021
Opening of the Conference -
Prof. Charles Boucher Memorial Lecture: The Story of Hepatitis C: Translating Science to Clinical Reality
Harvey J. Alter, MD, MACP
NIH Clinical Center's Department of Transfusion Medicine, United States
Opening Speech
Brigitte Touadera (First Lady of the Central African Republic)
H.E. Madam Brigitte Touadera, The First Lady of Central African Republic
Central African Republic
Update on Hepatitis Statements / Guidelines / Policies
Olufunmilayo Lesi, MD, MBA, FWACP, FMCP
World Health Organization, Switzerland
Session 1: Hepatitis Care After COVID-19 -
Diagnostics / Prevention During COVID-19
Sonjelle Shilton
FIND, Switzerland
Setting Up Networks - Project ECHO
Sanjeev Arora, MD, MACP, FACG
University of New Mexico Project ECHO, United States
Service Delivery – Community Perspective
Manal Ghazzawi, BPharm(Hons), PharmD, FPCP, MPH
KnowHep Foundation Sierra Leone, Sierra Leone
Session 2: Vaccination Opportunities -
Hepatitis A & E Vaccination Guidelines
Rakesh Aggarwal, MD, DM, MSc
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India
Vaccination of Healthcare Workers - Opportunities for Hepatitis B Prevention
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
Introduction to Birth Dose Vaccination
Julien Kabore, DDS, MPH
WHO, Republic of the Congo
Experience from Ethiopia
Mulat Nigus, MPH
Ministry of Health – Ethiopia
Experiences from The Gambia
Maud Lemoine, MD, PhD
Imperial College London, United Kingdom
Abstract-Driven Presentations
Key Considerations for the Introduction of Hepatitis B Birth Dose Vaccine in Cameroon
#1 - Delphine Kamga, Cameroon
A Community of Practice for the Introduction and Scale-up of Hepatitis B Birth Dose Vaccination in Africa: Challenges, Opportunities, and Lessons Learned
#2 - Henry Njuguna, United States
Day 2 - Friday, 10 September 2021
Session 3: Viral Hepatitis in Africa -
Elimination of Hepatitis C in Children
Manal Hamdy El-Sayed, MD, PhD
Ain Shams University, Egypt
Tracking Viral Hepatitis in Africa
Nafiisah Chotun, PhD, FRSPH, MRSTMH
Africa Centres for Disease Control and Prevention (Africa CDC), Ethiopia
Round Table Discussion -
Country - Experiences - Rwanda (HCV)
Sabin Nsanzimana, MD, MSc, PhD, FRCP
Rwanda Biomedical Center, Rwanda
Country - Experiences - Egypt (HCV)
Wahid Doss, MD
Cairo University, Egypt
Country - Experiences - Uganda (HBV)
Ponsiano Ocama, MBChB, MMed, PhD, FCP(ECSA)
Makerere University College of Health Sciences, Uganda
Country - Experiences - Senegal
Fatou Fall, MD
Hôpital Principal de Dakar, Senegal
Country-Experiences - Cameroon
Christian Tzeuton, MD
Douala Medical School / Société Camerounaise de Gastro-Entérologie, Cameroon
Session 4: Oral Abstract Presentations -
Abstract-Driven Presentations
Long Term Follow up of Chronic Hepatitis B Cohort in Africa; The Prolifica Gambia Experience
#5 - Isatou Mahmoud, Gambia
Assessment of Fibrosis Markers in HEPSANET: A Collaborative Network of Hepatitis B Cohorts in Sub-Saharan Africa
#6 - Asgeir Johannessen, Norway
Age Cohort Screening for Hepatocellular Carcinoma in an African Population
#7 - Jireh Makpu, Nigeria
Session 5: Management of Hepatoma in an African Setting -
Surgical Treatment of HCC
Asare Offei, MBChB, MGCS, FWACS
Korle-Bu Teaching Hospital / University of Ghana Medical School, Ghana
Systemic Therapy for HCC in Africa
Ashraf Omar, MD, FAASLD
Cairo University, Egypt
Day 3 - Saturday, 11 September 2021
Session 6: Fatty Liver Disease -
Global Overview on Fatty Liver Disease
Jeffrey V. Lazarus, PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain / CUNY Graduate School of Public Health and Health Policy, United States
Models of Care
Abdelmounem Abdo, MD
Ibn Sina Hospital, Sudan
Session 7: Oral Abstract Presentations -
Abstract-Driven Presentations
Velpatasvir-Based Regimens in Treatment-Naïve and Treatment-Experienced Adults with Resistant Hepatitis C Virus Genotype 4 Subtypes Endemic to Sub-Saharan Africa: Findings from the SHARED-3 Study in Rwanda
#8 - Fabienne Shumbusho, Rwanda
Values and Preferences for Hepatitis C Self-Testing Among the General Population and Healthcare Workers in Rwanda
#9 - Janvier Serumondo, Rwanda
Genedrive® Point of Care Qualitative Testing In a Pilot Hepatitis C Treatment Program
#10 - Vanessa Hechter, South Africa
EILF-Italian Migrants Study: An HCV and HBV Micro Elimination Pilot Project
#11 - Giuseppe Colucci, Italy
Have a Heart, Save My Liver! Who Has Access to the Cure in Africa?
#12 - Joelle Dountio O., United States
Session 8: Hepatitis Comorbidities -
Comorbidities - Obesity
Shira Zelber-Sagi, BSc, RD, PhD
University of Haifa / The Tel-Aviv Medical Center, Israel
Comorbidities - Alcohol and Khat Abuse
Asgeir Johannessen, MD, PhD
Tønsberg Hospital / University of Oslo, Norway
Country - Experiences - Egypt - Obesity/HT
Imam Waked, MD, FRCP, FAASLD
National Liver Institute (NLI), Egypt
Country - Experiences - Nigeria (NAFLD)
Charles Onyekwere, MBBS, FMCP, FACP, FASGE, AGAF
Lagos State University College of Medicine, Nigeria
Overview
Image
colda
Welcome

The Conference on Liver Disease in Africa (COLDA) 2021 took place as a highly successful virtual conference from 9-11 September. If you would like to watch the recordings from the conference, please go ahead and register to enter the virtual conference portal.

Download the Group Photo here

_________

Organized by the SHARE Global Health Foundation in close collaboration with regional societies, COLDA 2021 aimed at empowering healthcare professionals (HCPs) to diagnose, prevent, treat, and achieve a cure for liver diseases for the benefit of patients in Africa. As this was the 4th COLDA, we continue to cultivate a platform that provides a unique opportunity for clinicians, researchers, policymakers, industry representatives, and other healthcare professionals in the African region. Together with the support from an international community of experts, they exchanged knowledge on the latest developments and achievements in the management of viral hepatitis and liver disease with a special focus on the African context.

This highly scientific and educational abstract-driven conference consisted of keynote speeches, state-of-the-art lectures, oral and poster abstract presentations, roundtable discussions, and stimulating debates with ample time for discussion.

We are certain that the conference will act as a catalyst for translating science into clinical practice while promoting medical education in the field of hepatology and setting up collaborations within the African region. Everyone had an exceptional opportunity to share and acquire knowledge, as well as experience a wide spectrum of topics related to liver disease.

Chairs 2021
The SHARE Global Health Foundation

The SHARE Global Health Foundation is a non-profit organization dedicated to advancing global health by sharing and implementing expertise and evidence-based knowledge internationally.
SHARE focuses on identifying innovative educational programs and implementation strategies to empower physicians, community representatives, and stakeholders in low- and middle-income countries with the knowledge needed to improve services and policies in both governmental and private institutions. 

Visit the SHARE website for more information. 

share foundation

General Information 

Who Should Attend?
• Physicians
• Hepatologists
• Gastroenterologists
• Researchers
• Other healthcare professionals (nurses, clinical officers, community health workers, among others)
Meeting Objectives
COLDA aims to:

- Gather experts from the African region involved in the research, diagnosis, and treatment of liver diseases in an interactive conference setting;

- Discuss the diagnostic, therapeutic, and preventative efforts of liver disease tailored to regional and local needs, translating best practices into daily practice guidelines and policies;

- Contribute towards hepatitis elimination efforts;

- Leverage on the findings from international studies through the delivery of updates from major meetings that can be applied at the local and regional level to combat liver diseases;

- Facilitate a robust dialogue among participants through interactive networking and a networking reception; and

- Foster new and lasting interdisciplinary partnerships and collaborations among various researchers to improve knowledge sharing with aim of combating liver diseases in Africa.
Learning Objectives
After participating in COLDA, participants will be able to:

- Discuss the epidemiology and treatment of liver disease at an individual and population level;

- Ensure the knowledge and availability of HBV and HCV therapy and their correct usage;

- Discuss evolving modalities of monitoring liver disease and their availability in the African setting; and

- Update on new developments in the investigation of liver disease and their use in an African setting.

Practical Information 

Certificate of Attendance
A certificate of attendance will be sent to participants after they have attended the conference and completed the post-meeting survey.
Language
The official conference language will be English.
Enduring Materials
Enduring materials will be available here shortly after the conclusion of the conference.
Disclaimer
The conference is organized by the SHARE Global Health Foundation and the conference secretariat is Virology Education BV. This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The conference organizer and conference secretariat cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this conference. The conference organizer and conference secretariat disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the conference organizer and conference secretariat do not accept responsibility for any applicable insurances. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official conference sessions. Only the official medical writer appointed by the conference organizer and conference secretariat may make recordings. All presentations will be posted here as soon as possible after the conference is finished, provided that the speaker has given permission to do so.
Case Presentations

Case Presentation submission is closed.

Deadline: Friday, 16 July 2021

COLDA strongly believes in the value of featuring Young Investigators and professionals to ensure broad and inclusive capacity building. This year's program provides an opportunity for you to share your data by submitting a Case Presentation.

Case Presentation Topics Include:

  • HBV Disease Management
  • HCV Disease Management

The registration fee will be waived for all case presenters that qualify as Young Investigators.

How to submit your case presentation?

Please submit your case presentation through the case presentation portal using one of the three forms below:

  • HBV, Adult Case
  • HBV, Adult Pregnant Case
  • HCV Case
Registration
The registration fee will be waived for all case presenters that qualify as Young Investigators.

To be eligible as a young investigator, one should be:
- 35 years of age or younger, and
- either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years.

An application form (can be found on the Registration page) needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the conference. Virology Education will contact the young investigator with instructions regarding the registration procedure.
Terms and Conditions
The SHARE Global Health Foundation (hereinafter “SHARE”) is the Meeting Organizer of COLDA 2021. Virology Education BV, the Conference Secretariat, (hereinafter “VE”) will be handling the case submission process for COLDA 2021. Both SHARE and VE may be collectively referred to as “Parties”.

By submitting a case presentation, the submitter hereby agrees to the following terms and conditions.

a) Errors
VE cannot be held responsible for any typing, spelling, or language errors in the submitted case submission(s).

b) Case submission topic
The Organizing Committee of COLDA 2021 may decide to allocate the submitted case submission to a different topic than the topic for which it was submitted.

c) Case submission consent
By submitting a case submission, the submitter agrees that they have received the consent of their co-submitters to do so.

d) Case submission presenter attendance
At least one listed submitter of each accepted case submission must register (paying the relevant registration fee) and attend the meeting to present the case submission.

e) Final decision on case submission status
The Organizing Committee’s decision on the case presentation is final and no further correspondence on the status of the case submission will be entered into.

f) Copyright and publication
The case submitter grants the Parties a non-exclusive, perpetual, irrevocable, royalty-free license to use, reproduce, distribute, broadcast, and rebroadcast their case presentation. The case presentation will be made available for viewing on www.academicmedicaleducation.com and other webpages owned and/or operated by the Parties. This license may or may not be used for commercial gain. This permission/license is granted to Parties free of charge. VE shall be under no obligation to pay for this permission/license. This license does not change the fact that the case submitter(s) retain copyright ownership of their presentation.

The case submitter is responsible for adequately displaying appropriate copyright notices on any and all of their materials which is to be submitted to VE. The case submitter agrees and understand that VE takes no responsibility for registering any copyright on behalf of them. Case submitters hereby accept and confirm that their case presentation contains no text for reference that is either directly or indirectly defamatory, or is otherwise unlawful, invades individual privacy, or infringes on any proprietary right or statutory copyright. By submitting a case presentation to VE, submitters affirm that their case presentation is their own original work or that they have obtained permission at their own expense from the copyright holder (of any and all data and/or text) for publication and will submit signed documentation showing permission for use to VE at the time of submission of the case presentation.

g) Withdrawal policy
If the case submission presenter wishes to withdraw their case submission, they must do so at least 6 weeks before the conference dates.

h) Communications
All communications regarding this case submission will be directed to the submitter. It is the responsibility of the submitter to inform the co-submitters of the case submission acceptance status.

i) Indemnification
Case submitters agree to indemnify and hold harmless the Parties, their agents and representatives should the material presented or provided for publication be determined to defame, libel, or slander an individual or organization, violate the confidentiality of any individual or organization, or infringe on another's copyright.
Submission
Presenters can submit their cases electronically until the submission deadline.
Click on "Submit Here" at the top of the page and you will be redirected to the submission portal. Please follow the step-by-step directions to upload the case.
Make sure to upload your case using one of the three forms made available: HBV Adult Case, HBV Adult Pregnant Case, or HCV Case.
Selection
A number of case presentations will be selected to be included in the program. The presenters of these cases will be asked to present their cases and engage in a short discussion.
Committees
Organizing Committee
Ward, John 2023
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Committee

To augment the organizing committee, the following are scientific committee members

  • Mary Afihene, MBChB, FWACP – Kwame Nkrumah University, Ghana 

  • Geoffrey Dusheiko, MBBCh, FCP, FRCP - Kings College Hospital, United Kingdom

  • Alice Guingané, MD, MPH - Bogodogo University Hospital Center / University of Montpellier, Burkina Faso / France

  • Emmanuel Musabeyezu, MD, FCP – King Faisal Hospital, Rwanda

  • Yvonne Nartey, MBChB, MSc, MPhil – Cape Coast Teaching Hospital, Ghana

  • Gibril Ndow, MD – Imperial College London / London School of Hygiene & Tropical Medicine, The Gambia

  • Ramou Njie, MD, PhD, FRCP, FWACP - University of The Gambia Medical School, The Gambia

  • Peter Olupot-Olupot, MD, MPH, PhD - Busitema University, Uganda

  • John Rwegasha, MBChB, M.MED, FRCP, MSc - Muhimbili National Hospital, Tanzania

  • Edford Sinkala, MD, PhD - University Teaching Hospital / University of Zambia, Zambia

  • Sonjelle Shilton, MPH - Foundation for Innovative New Diagnostics (FIND), Switzerland

  • Elijah Songok, MD, PhD - Kenya Medical Research Institute, Kenya

  • Christian Tzeuton, MD – Douala Medical School / Société Camerounaise de Gastro-Enterologie, Cameroon

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

Scholarships

Scholarship Application is Closed

Scholarships

SHARE Global Health Foundation, with support from the industry, is offering scholarships to attend COLDA 2021. The scholarship covers registration and/or a data bundle. 

The scholarships are supported by industry. These companies will have no control, influence, or involvement in the selection of any attendees.

The scholarship application deadline was Friday, 25 June 2021, at 23:59 CEST/SAST/CAT.

Scholarship Providers
What is Expected from the Scholarship Recipients?

All scholarship awardees are required to attend the full conference. Awardees must sign in at the beginning of each meeting day and sign off at the end of each day as requested by the Conference Organizer. At the close of the conference, awardees must have completed the daily and overall conference evaluations.

Recipient will provide post-conference feedback and a summary about his/her conference experience within one month after the end of the conference. The feedback questionnaire will be an online survey with the recipient providing feedback on their experience at the conference, scholarship procedure, and how they will implement the knowledge acquired at the conference in their daily practice. The questionnaire will be sent to each recipient by email within one week after the conclusion of the conference.

What does the Scholarship Cover?
There are 3 types of scholarships:
- Registration Only
- Data Bundle Only
- Registration & Data Bundle 
Eligibility
Applicants must:
- Be proficient in English to interact with faculty and fellow attendees
- Be actively involved in the field of liver diseases in Africa
- Be able to show benefits to their patients / research / community from attending the meeting
- Be willing and able to share information learned at the meetings with a larger community

The Conference organizer will automatically decline all scholarship applications that do not conform to the eligibility terms.
Application Procedure
The scholarship applications must be submitted online through our Scholarship Application Portal by 25 June 2021. The applicant will be asked to submit a motivational letter (max. 200 words) describing how their patients/research/community will benefit from the knowledge gained at this meeting, and their knowledge dissemination strategy, a CV, and a letter of recommendation (optional).

- All applications will be acknowledged upon receipt.
- All applications will be reviewed by an independent Scholarship Review Committee.
- All applicants will be notified about the status of their application no later than 21 July.
- Successful applicants will be sent a scholarship agreement.
- After receipt of the signed scholarship agreement, successful applicants will receive instructions for logistical arrangements.
Selection Criteria
- Professional background;
- Country of residence;
- Recommendation by your supervisor;
- Demonstrable benefits to patients / research / community by the knowledge to be gained at this meeting;
- Strategy of knowledge dissemination;
- Young Investigator; and
- Abstract presenters.
Scholarship Terms and Conditions
• The applicant will attend the entire conference program.
• The applicant will provide the completed post-meeting feedback and summary to the conference organizer.
• The applicant must attend the conference and confirm that they will be responsible for all other costs associated with conference attendance such as internet usage and use of a computer device. If the applicant has received a scholarship for an internet bundle, the Conference Organizer will not be responsible for providing additional internet data or compensating the applicant for additional internet usage if they exceed the data available in the internet bundle scholarship.
• The applicant will not hold the Conference Organizer liable for any losses, costs, expenses, causes of action, claims, and suits for property damage, theft of property, or personal injury (including death) arising in connection with the Scholarship and participation in the Conference.
• The applicant agrees to be responsible for taking out their relevant own insurance policies.
• The Scholarship is non-transferable.
• Incomplete Scholarship applications will not be considered.
• Retrospective Scholarship applications will not be considered.
• Conference organizer cannot be held responsible for any incorrect information that is submitted through the Scholarship application portal.
• Scholarship applications will be considered until the exhaustion of funds.
• The Scholarship applicants will be notified of the decision by email. Successful applicants will be notified with further instructions.
• Conference organizer reserves the right to make the final decision regarding all Scholarship applications, which cannot be disputed.
Support
Supporter Level Sponsor
Symposium Supporters

Supported by Gilead Sciences Europe Ltd. (“Gilead”) who provided funding. Gilead has had no input or influence into the content of the Conference or any presentations.

Support Our Initiative

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in liver diseases in Africa.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Karin Siebelt at Karin.Siebelt@share-foundation.com or call +31 30 230 7149
 
Benefits of Support 
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Verbal acknowledgment during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, program book, the streaming platform, and our website
  • Digital advertising opportunities 
  • Social media shout-outs
  • Logo on the digital conference bag 
  • Exhibition

 
*Subject to the support level

Endorser
Language